Interim Final Rule (IFC), CMS-3401-IFC, Updating Requirements for Reporting of SARS-CoV-2 Test Results by Clinical Laboratory Improvement Amendments of 1988 (CLIA) Laboratories, and Additional Policy and Regulatory Revisions in Response to the COVID-19 Public Health Emergency

Attention: Clinical Laboratories Please share this information with individuals in the following roles: Accreditation Coordinator Quality Director Medical Director – Laboratory Key points: ALL laboratories regardless of CLIA type (including those with a Certificate of Waiver and Point of Care testing) must report both positive and negative results to their state or local public health…

Read more

Interim Final Rule: Medicare and Medicaid Programs, Clinical Laboratory Improvement Amendments (CLIA), and Patient Protection and Affordable Care Act; Additional Policy and Regulatory Revisions in Response to the COVID-19 Public Health Emergency

Attention: Acute Care Hospitals Critical Access Hospitals Clinical Laboratories Please share this with individuals in the following roles: Chief Nursing Officer Accreditation Coordinator Infection Control Program Leader Quality Director Medical Director – Laboratory Services Key points: On August 25, 2020, CMS announced regulatory changes. The changes were published in the Federal Register on September 2,…

Read more